Nasus Pharma Ltd Debt Instrument, Fair Value Disclosure
Nasus Pharma Ltd (NSRX) had Debt Instrument, Fair Value Disclosure of $4.14 thousand as of 2025-06-30, per its 6-K filed 2025-12-29.
Financial Statements › Notes › Debt Instruments
us-gaap:DebtInstrumentFairValue · last filed 2026-03-25
- 2025-06-30: Debt Instrument, Fair Value Disclosure $4.14K.
- 2024-12-31: Debt Instrument, Fair Value Disclosure $3.40K.
| Period end | Debt Instrument, Fair Value Disclosure |
|---|---|
| 2025-06-30 | $4.14K 6-K · filed 2025-12-29 |
| 2024-12-31 | $3.40K 20-F · filed 2026-03-25 |